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Introduction: The vulnerability of pediatric myocardium to ischemia is 
poorly documented in the clinical setting. Methods: Serial measurements of 
serum concentrations of myoglobin, the MB isoenzyme of creatine kinase, 
and cardiac troponins T and I and their respective areas under the curve 
were obtained, with particular reference to age and ischemic time, in 80 
children undergoing cardiac operations. Sixteen (the control group) did not 
require cardiopulmonary bypass and 64 did. Results: In the control group 
there were increases (p < 0.01) in myoglobin and creatine kinase MB 
isoenzyme but no increase in cardiac troponin T or I; by contrast, the group 
treated with cardiopulmonary bypass had significant increases in all four 
markers but with differing temporal patterns. Younger age (especially < 12 
months) was a highly significant explanatory variable only for the release of 
cardiac troponins T and I, and ischemic time was a significant explanatory 
variable for the release of creatine kinase MB isoenzyme, cardiac troponins 
T and I, but not myoglobin. In comparison with previous studies in adults. 
creatine kinase MB and cardiac troponin T concentrations were three times 
greater in children than in adults. Conclusions: This study supports the 
specificity of cardiac troponins T and I as markers of myocardial injury 
after pediatric cardiac operations and defines the importance of age and 
ischemic time in determining their release. In comparison with previous 
data in adults, our results raise the possibility that the pediatric heart may 
be more vulnerable to the effects of ischemia and reperfusion. Cardiac 
troponins will permit comparison of new myocardial protective strategies 
or other potentially therapeutic myocardial interventions. (J Thorac Car- 
diovasc Surg 1997:113:728-35) 
A dvances in surgical and anesthetic techniques accompanied by refinements in extracorporeal 
perfusion technology have led to significant im- 
provements in the results of pediatric cardiac sur- 
gery during the past decade, prompting efforts at 
complex operations in increasingly ounger chil- 
dren. 
The vulnerability of pediatric myocardium to the 
effects of ischemia and reperfusion in clinical prac- 
tice is, however, poorly documented. On the basis of 
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evidence derived largely from studies on the hearts 
of healthy young animals, 14 the immature myocar- 
dium has traditionally been considered to be more 
resistant to hypoxia and ischemia than its adult 
counterpart. There is very little confirmatory data in 
the clinical setting. However, more than a decade 
ago Bull, Cooper, and Stark, 6 in a study of 400 
pediatric patients, suggested that half of the postop- 
erative deaths were attributable to inadequate myo- 
cardial preservation despite crystalloid cardioplegia. 
In addition to differences in structure, function, and 
biochemistry between the healthy immature and 
mature heart, 7 the situation is further complicated 
in patients with congenital heart disease because the 
myocardium ay be volume Overloaded or pressure 
overloaded (or both). Smolenski and c011eagues 8 
reported an increased release of lactates, phos- 
phates, and purines in the coronary sinus effluent of 
children aged 2 to 10 years compared with the levels 
of these substances in adults during cardiac opera- 
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tions. These observations imply that children's 
hearts are more metabolically vulnerable to the 
effects of ischemia, cardioplegic arrest, and reperfu- 
sion. We 9 have recently reported greater elevations 
of the MB isoenzyme of creatine kinase (CK-MB) 
and cardiac troponin T (cTnT) after pediatric sur- 
gery compared with that seen in adults, but we could 
not evaluate the effects of age and ischemic times. 
In the present study, we per formed serial mea- 
surements of serum concentrations of myoglobin, 
CK-MB, and the cardiac troponins T and I (cTnT 
and cTnI) in 80 consecutive children undergoing 
operations for congenital heart disease. The study 
included 16 children undergoing procedures not 
requiring cardiopulmonary bypass (CPB) (the con- 
trol group) and 64 children undergoing cardiac 
operations requiring CPB (the CPB group). In 
particular, we examined the effects of age and 
ischemic t ime on the release of these biochemical 
markers. 
Methods 
The study was approved by the Ethical Committee of 
the Royal Brompton Hospital, and consent obtained from 
the guardians of the patients. 
Patients. The patients comprised 80 children undergo- 
ing operations for congenital heart disease, 16 not requir- 
ing CPB (the control group) and 64 requiring CPB (CPB 
group). The current study includes data from a previous 
pilot study 9 and the same biochemical measurements in 
an additional 40 patients. 
Surgery. The control patients underwent thoracotomy 
but no direct cardiac procedure. In the CPB group 
myocardial protection was obtained with St. Thomas' 
Hospital cardioplegic solution (30 ml/kg) at 4°C admin- 
istered under gravity through the aortic root every 30 
minutes and additional topical hypothermia with slush ice 
as necessary. Systemic hypothermia to between 28 ° and 
32 ° C was used in all patients unless circulatory arrest was 
required, in which case systemic temperature was reduced 
to between 15 ° and 18 ° C. 
Blood samples. Serum concentrations of myoglobin, 
CK-MB, cTnT, and cTnI were measured serially before 
and 1, 6, 24, and 72 hours after the operation. Areas under 
the curve (AUC), representative of the total release of the 
biochemical markers, were calculated from the respective 
curves according to the formula developed by Shell and 
Sobel. t° 
Biochemical analysis. Biochemical analysis has been 
described previously. 9 Myoglobin was measured with a 
double antibody radioimmunoassay technique (Myoglo- 
bin RIA Test Kit, Biogenesis, Bournemouth, United 
Kingdom); CK-MB was directly measured by micropar- 
ticle enzyme immunoassay with the ABBOTT IMX 
CK-MB kit (Abbott Diagnostics Division, Maidenhead, 
United Kingdom); cTnT and cTnI were both measured by 
enzyme-linked immunoadsorbent assays (Elisa Troponin 
Table I. Explanatory variables for the postoperative 
release of the biochemical markers in the CPB group 
(n = 64) 
Variable Median Q25 Q75 
Age (rap) 7 
Ischemic time (min) 36 
CPB time (min) 59 
Temperature (°C) 23 
Total circulatory arrest 48% 
(yes = 1, no = 0) 
Atriotomy + ventriculot- 69% 
pray (yes = 1, no = 0) 
Operation 
Atrial septal defect 19.7% 
(yes = 1, no = 0) 
Ventricular septal defect 34.4% 
(yes = 1, no = 0) 
Tetralogy of Fallot 8.2% 
(yes = 1, no = 0) 
Atrial switch operation 18.0% 
(yes = 1, no = 0) 
Other (yes = 1, no = 0) 19.7% 
4 48 
24 56 
50 86 
15 30 
025 and Q75, Lower and upper quartiles. 
T kit, Boehringer Mannheim, United Kingdom, and Tro- 
ponin I Pasteur kit, Sanofi Diagnostics Pasteur Ltd). 
Statistics. Data were analyzed with the STATGRAPH- 
ICS statistical program (STATGRAPHICS, version 6.0, 
Manugistics, Inc.). The Mann-Whitney U test was used for 
the comparison of continuous data between groups and 
Fisher's exact test for categoric data. Forward stepwise 
multiple regression analysis was used to identify explana- 
tory variables that influenced the postoperative r lease of 
biochemical markers, as expressed by the AUC developed 
from the formula by Shell and Sobel. 1° 
Explanatory variables are summarized in Table I. In the 
multiple regression model the AUC of biochemical markers, 
age, and ischemia time underwent a logarithmic transforma- 
tion as dictated by the analysis of residuals. Results are 
expressed as median and upper/lower quartiles. 
Differences were considered statistically signifcant at a 
probability level ofp < 0.05. 
Results 
Patients. Clinical data regarding the control and 
CPB groups are provided in Table IL The median 
(and upper and lower quartiles) age of the control 
patients was 3 months (1 and 7 months) and that of 
the CPB group 7 months (4 and 48 months) (p < 
0.01). 
Operations. Operat ions per formed in the non- 
CPB group included six repairs of coarctation, four 
closures of patent ductus arteriosus, five modified 
Blalock-Taussig shunts, and one banding of the 
pulmonary artery. 
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Table II. Comparative clinical data between control 
and CPB groups 
Control group CPB group 
Variable (n = 16) (n - 64) p Value 
Age (mo) 3 (1-7) 7 (4-48) 0.0117 
Postoperative ntilation (days) 1 (1-3) 2 (1-3) 0.7401 
Discharge (days) 7 (6-8) 7 (5-8) 0.7687 
Death 0 8% 0.8423 
Results are expressed as median and lower/upper quartiles. Mann-Whitney 
U test and Fisher's exact est were used to compare data between the two 
groups. 
In the CPB group operations were undertaken for 
atrial septal defect (n = 13), ventricular septal 
defect (n = 16), tetralogy of Fallot (n = 6), simple 
arterial transposition (n = l l) ,  atrioventricular ca- 
nal (n = 6), total anomalous pulmonary venous 
connection (n = 3), pulmonary artery conduit (n = 
2), anomalous coronary artery (n = 1), atrial switch 
(n = 1), mitral valve replacement (n = 1), pulmo- 
nary artery debanding (n = l), aortic valve replace- 
ment (n = 1), aneurysm of the membranous septum 
(n = 1), and atrial septectomy (n = 1). 
Serial changes in biochemical markers. Serial 
changes in myoglobin, CK-MB, cTnT, and cTnI in 
the control and CPB groups are illustrated in Fig. 1, 
A to D, respectively. So that comparative analysis 
could be done, the median and upper and lower 
quartiles for each biochemical marker at a specific 
time point and the total AUC are given in Table III. 
Control group. In the control group there were 
highly significant (p < 0.01) increases in myoglobin 
(Fig. 1, A) and CK-MB (Fig. 1, B) but no increase in 
cTnT (Fig. 1, C) or cTnI (Fig. 1, D). Myoglobin reached 
peak concentrations 1 to 6 hours after the operation 
and decreased by 24 hours to reach preoperative 
values by 48 hours. In contrast, CK-MB peaked be- 
tween 6 and 24 hours after the operation, remained 
significantly elevated at 48 hours, and returned to 
preoperative values by 72 hours. 
CPB group. The CPB group showed highly signif- 
icant increases in all four biochemical markers (Fig. 
1, A to D) but with differing temporal patterns. 
Similar size and temporal changes in myoglobin in 
the control and CPB groups (Fig. 1, A) resulted 
in similar AUCs. The magnitude of increase in 
CK-MB (Fig. 1, B) was significantly greater between 
1 and 6 hours, but not between 24 and 72 hours, in 
the CPB group, resulting in a significantly greater 
AUC compared with that of the control group. In 
contrast to patients in the control group, who 
showed no elevation in cTnT or cTnI, there were 
highly significant increases in both cardiac troponins 
(Fig. l, C and D), reaching a peak at 6 hours. 
Subsequently, cTnI showed a more rapid fall from 
peak levels than cTnT, so that although both cTnT 
and cTnI remained significantly elevated at 72 
hours, the magnitude of this increase over preoper- 
ative levels was less for cTnI (approximately six 
times) than for cTnT (approximately 30 times). 
Variables influencing release of the biochemical 
markers after CPB. Variables influencing the re- 
lease of the biochemical markers after CPB are 
presented in Tables IV, A to IV. D. 
Younger age was a highly significant explanatory 
variable for the release of cTnT and cTnI in both 
bivariate and multivariate analysis (Tables IV. A to 
IV, D, Figs. 2 and 3) but not for myoglobin or 
CK-MB. Ische mic time was a significant explanatory 
variable for the release of CK-MB, cTnT, and cTnI 
but not for myoglobin. The presence of an atriotomy 
or ventriculotomy was a significant explanatory vari- 
able for the release of cTnT and cTnI but not 
myoglobin or CK-MB. whereas repair of a VSD was 
a significant explanatory variable for the release of 
CK-MB and cTnI. Neither CPB time nor tempera- 
ture was an explanatory variable for the release of 
any biochemical marker. 
Clinical outcome. Five patients from the CPB 
group (8%) died at the end of the operation or in 
the early postoperative period. Three had under- 
gone an arterial switch operation, one an atrial 
septectomy, and one an atrioventricular canal re- 
pair. These patients' operations were all character- 
ized by significantly longer ischemic times than 
those of the patients who survived (90 [65 to 99] vs 
35 [23 to 47] minutes). In the CPB group the median 
(and upper and lower quartiles) period of ventila- 
tion was 2 days (1 and 3 days) and the mean hospital 
stay was 7 days (5 and 8 days). 
Discussion 
Before the results of our study are discussed, it is 
appropriate to comment on its rationale and limita- 
tions. Measurement of cardiac performance is prob- 
ably the best method of assessing myocardial injury, 
but it is difficult in clinical practice 11 and may not 
distinguish between functional impairment and sub- 
tle levels of irreversible injury. Biochemical markers 
are easily measured from blood samples and detect 
even minor levels of myocardial injury in all pa- 
tients. Caveats concerning the myocardial specificity 
of biochemical markers after cardiac surgery (e.g., 
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Fig. 1. Serial changes in myoglobin (A), CK-MB (B), cTnT (C), and cTnI (D) in the control and CPB 
groups. Results expressed as median and lower/upper quartiles. *p < 0.05 between groups at corresponding 
time points. 
myoglobin and CK-MB are released predominantly 
but not exclusively from myocardium after cardiac 
surgery) can be resolved by the measurement of
cTnT and cTnI, highly specific myocardial isoforms 
of the respective subunits of the troponin regulatory 
complex. In a preliminary report, we 9 confirmed the 
cardiac specificity of these markers after pediatric 
cardiac surgery and suggested that release of tro- 
ponins might be greater after pediatric than adult 
cardiac surgery. In that study, however, there were 
insufficient patients to investigate the effects of age 
and ischemic time on troponin release. 
The major limitations of this study, as with most 
studies of myocardial injury after pediatric cardiac 
surgery, are the heterogeneous nature of the pa- 
tients with their differing underlying pathophysio- 
logic processes and the various types of operations 
performed. Nevertheless, the current study was of 
sufficient size to allow some valuable conclusions to 
be drawn regarding myocardial specificity of the 
various biochemical markers, the magnitude and 
temporal pattern of serial changes in their plasma 
concentrations after cardiac surgery, and the effects 
of age and ischemic time on their release. 
The results of our study suggest the following: 
1. cTnT and cTnI are specific markers of myocar- 
dial injury after pediatric ardiac surgery. Whereas 
myoglobin and CK-MB increased significantly in 
both the control and the CPB groups, increases in 
cTnT and cTnI occurred only in the CPB group. 
2. Although congenital heart disease may result in 
abnormal myocardial function, particularly in pres- 
sure- or volume-overloaded hearts (or both), the 
normal serum levels of myoglobin, CK-MB, cTnT, 
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Table III. Time changes of biochemical markers of myocardial injury in pediatric cardiac surgery 
CBP group Control group 
(n = 64) (n = 16) 
Variable Sample size Median Q25 Q75 Median Q25 Q75 p Value 
cTnT (Ixg/L) 
Preoperative 80 0.1 0.1 O, 1 0.1 0.1 0.1 
1 hr 79 2.8 1.1 5.4 0.1 0.1 0.4 
6 hr 78 5.3 1.8 8.6 0.2 0.1 0.4 
24 hr 75 3.6 1.3 5.9 0.2 0.1 0.3 
48 hr 75 3.4 1.7 6.5 0.3 0.1 0.4 
72 hr 75 2.8 1.3 4.6 0.1 0.1 0.7 
cTnT-AUC (i.tg x hr/L) 75 262 108 390 10 7 20 
cTnI (~tg/L) 
Preoperative 80 0.05 0.01 0.10 0.02 0.01 0.05 
1 hr 79 0.79 0.45 1.25 0,04 0.01 0.12 
6 hr 78 1.22 0.72 2.24 0.03 0.01 0.34 
24 hr 75 0.82 0.47 1.90 0.08 0.01 0.15 
48 hr 75 0.39 0.26 0.78 0.04 0.01 0.07 
72 hr 75 0.31 0.17 0.57 0.02 0.01 0.03 
cTnI-AUC (lag × hr/L) 75 56 37 127 4 1 7 
CK-MB (/~g/L) 
Preoperative 80 3.5 2.3 5.9 2.7 2.4 3.6 
1 hr 79 71.0 37.3 119.5 9,9 6.5 30.3 
6 hr 78 58.4 33,0 111.3 23.1 12.3 39.2 
24 hr 69 23.0 15.2 35.2 20.7 10.8 33.4 
48 hr 69 6.5 3.7 14.5 6.1 4,5 13.1 
72 hr 69 3.3 2.5 6,1 3.9 1.9 6.0 
CK-MB-AUC (Ixg × hr/L) 69 1770 1162 2935 1058 646 t851 
MYOGLOBIN (/~g/L) 
Preoperative 37 25 25 30 25 25 
1 hr 36 279 168 420 264 136 335 
6 hr 36 158 108 222 225 124 319 
24 hr 36 105 65 182 115 71 145 
48 hr 36 28 25 46 25 25 25 
72 hr 36 25 25 30 25 25 25 
AUC (lag × hr/L) 36 6807 5176 10621 7713 4111 9071 
<0.0001 
< O. 0001 
0.0190 
O. 6650 
Mann-Whitney U test was used to compare AUC between the two groups. Thep values in the last column represent AUC differences between the two groups. 
Time-point marker values indicate the values used for the calculation of AUC. CPB, Cardiopulmonary bypass; cTnT, troponin T; cTnI, troponin I; AUC, area 
under curve (over 72 hours); Q25, Q75, lower, upper quartiles; NS, not significant. 
and cTnI before operation suggested that there was 
no ongoing structural damage. On the other hand, 
these dilated, hypertrophied, and hypoxic hearts 
may be more sensitive to the effects of ischemia and 
reperfusion. 
3. The magnitude and temporal release of the 
various biochemical markers differed within and 
between the control and CPB groups. Whereas 
serial changes in myoglobin were very similar in the 
control and CPB groups, leading to a similar AUC, 
a threefold increase in CK-MB in the CPB group 
compared with the control group between 1 and 6 
hours led to a doubling of the AUC despite similar 
concentrations between 24 and 72 hours. CTnT and 
cTnI were elevated only in the CPB group, with 
peak concentrations being reached at 6 hours; in 
contrast, concentrations of myoglobin and CK-MB 
peaked at 1 hour. Furthermore, whereas myoglobin 
and CK-MB had returned to preoperative concen- 
trations by 72 hours, both cTnT and cTnI remained 
significantly elevated at 72 hours, with the respective 
increases over preoperative concentrations being 
approximately sixfold for cTnI and thirtyfold for 
cTnT. 
4. Multiple regression analyses showed that 
younger age correlated significantly with an in- 
creased release of cTnT and cTnI (but not myoglo- 
bin or CK-MB) and was particularly marked in 
children less than 12 months of age. Inasmuch as 
there is no evidence that the plasma clearance of 
cardiac troponins (or myoglobin or CK-MB) is 
different in younger patients, this implies a true 
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Fig. 3. Relationship between postoperative cTnI release, 
as expressed by the AUC, and age in pediatric ardiac 
surgery. Data analyzed by nonlinear egression analysis 
and analysis of variance for the full regression provided a
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and prediction limits. 
increase in myocardial injury in these patients. 
Whether this represents differing underlying path•- 
physiologic processes in the younger age group or an 
increased vulnerability of immature myocardium to 
the ischemia-reperfusion njury of cardiac surgery is 
not clear from our study. 
5. Duration of ischemic time, expected to be the 
strongest predictor of release of biochemical mark- 
ers, correlated most strongly with the release of 
cTnT and cTnI, more weakly with the release of 
CK-MB, and not with that of myoglobin. This is 
consistent with the increased specificity of the car- 
diac troponins. 
6. The presence of an atriotomy or ventriculotomy 
(or both) was itself a significant explanatory variable 
within the multiple regression analysis model for the 
release of cTnT and cTnI, presumably because of 
their increased cardiac specificity. We have no ob- 
vious explanation for the observation that operation 
for ventricular septal defect predicted release of 
CK-MB and cTnI but not cTnT. 
In comparison with previous tudies in which we 
measured concentrations of myoglobin, CK-MB, 
and cTnT (but not cTnI) in adults] 2-~4 the temporal 
response of the same biochemical markers, in terms 
of peaks and return to preoperative concentrations, 
was very similar to that in our pediatric population. 
However, whereas the peak myoglobin concentra- 
tion was similar in adults and children, the peak 
CK-MB and cTnT concentrations were approxi- 
mately three times greater in children and signifi- 
cantly exceeded the limits for detecting clinically 
relevant myocardial injury. 15 Conclusions regarding 
the implied differing vulnerability of adult and pe- 
diatric myocardium should be interpreted cautiously 
because of the differences in the underlying path•- 
physiologic processes, with those of adults being 
predominantly ischemic and those of the younger 
population being pressure-volume overload. 
Cardiac troponins are located within myocytes 
both in a small free cytosolic pool and in a larger 
Structurally bound fraction, at least in adults. 16 A 
proportion of circulating cardiac troponins detect- 
able in the first few hours after severe ischemia 
may be due to leakage from the cytosolic pool and 
may indicate reversible cell membrane injury. 
Inasmuch as the half-life of cTnT is only 2 hours, 
because of rapid plasma clearance, continued 
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Table IV, A. Forward stepwise regression model of cTnT-AUC (log lxg × hr/L) 
Variable Coefficient Standard error r p Value 
Constant  3.77 0.69 
Age (log months)  -0 .54  0.06 -8 .0  <0.0001 
Ischemia t ime (log minutes)  0.61 0.15 3.9 0.0003 
A _+ V (yes = 1. no = 0) 0.72 0.28 2.6 0.0139 
Adjusted R 2 = 0,66; residual standard error = 0.60: analysis of variance for the full regresnonp < 0.0001. cTnT-AUC, age, and ischemia time underwenr 
a logarithmic transformation tO achieve suitable linear relationships between the dependent variable and each continuous explanatory variable cTnT-AUC, 
Troponin T area under curve (over 72 hours); A = V. atriotomy -~ ventrieulotomy. 
Table IV, B. Forward stepwise regression model of cTnI-AUC (log I~g × hr/L) 
Variable Coefficient Standard error ~ p Value 
Constant  1.87 0.76 
Age  (log months)  -0 .26  0.07 3.45 0.0013 
Ischemia t ime (log minutes  ) 0.49 0.17 2.87 0.0064 
A _+ V (yes = 1. no = 0) 0.92 0.31 2.92 0.0057 
VSD (yes = 1. no = 0) 0.63 0.21 2.89 0.0062 
Adjusted R 2 - 0.48; residual standard error - 0.67: analysis of variance for the full regressionp < 0.0001. cTnI-AUC, age, and ischemia time underwent a 
logarithmic transformation to achieve suitable linear relationships between the dependent variable and each continuous explanatory variable, cTnI-AUC 
Troponin I area under curve (over 72 hours): A ~ V atriotomy = ventriculotomy: VSD. ventricular septal defect. 
Table IV, C. Forward Swpwise regresszon model of CK-MB-AUC (log tzg × hr/L) 
Variable Coefficient Standard error r p Value 
Constant  6.17 0.52 
Age  (log months)  0.07 0.06 1.03 0.3085 
Ischemia  t ime (log minutes)  0.35 0.13 2.67 0.0109 
VSD (yes = 1. no = 0) 0.55 0.18 3.03 0.0044 
Adjusted R 2 = 0.30; residual standard error = 0.54: analysis of variance for the full regressionp = 0.0008. CK-MB-AUC. age, and ischemia time underwent 
a logarithmic transformation to achieve suitable linear relationships between the dependent variable and each continuous explanatory variable. CK-MB-AUC. 
CK-MB area under curve (over 72 hoursl: VSD. ventricular septal defect. 
Table IV, D. Forward swpwise regression model of myoglobin-AUC (log ixg × hr/L) 
Variable Coefficient Standard error ~ p Value 
Constant  8.67 0.89 
Age Ilog months)  -0 .09  0.08 - 1.16 0.2579 
Ischemia t ime (log minutes)  0.12 0.24 0.50 0.6225 
ASD ryes = 1. no = 01 -0 .30  0.33 0.90 0.3786 
Adjusted R z = 0.10; residual standard error = 0.54; analysis of variance for the full regression p = 0.1663. Myoglobin-AUC. age, and ischemia time 
underwent a logarithmic transformation to achieve suitable linear relationships between the dependent variable and each continuous explanatory variable. 
Myoglobin-AUC, Myoglobin area under curve (over 72 hoursk ASD. atrial septal defect. 
increases after 12 hours probably indicates true 
degradation of myofilaments. One possible expla- 
nation for the difference in magnitude and tem- 
poral responses of cTnT and cTnI is that cTnI is 
only expressed in cardiac muscle throughout on- 
togeny, whereas cTnT is expressed in fetal skeletal 
muscle and may be reexpressed in injured human 
skeletal muscle. 17' 18 
In summary, this study supports the specificity of 
cTnT and cTnI as markers of myocardial injury after 
pediatric cardiac surgery and defines the importance 
of age and ischemic time in determining their re- 
lease. Our results, in comparison with previous data 
in adults, raise the possibility that the pediatric heart 
may be more vulnerable to the effects of ischemia 
and reperfusion than the adult heart. Cardiac tro- 
ponins are useful for providing comparative data 
and will aid assessment of new myocardial protec- 
tive strategies or other potentially therapeutic myo- 
cardial interventions. 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 113, Number 4 
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